Mutant IDH1 inhibitor ivosidenib (IVO; AG-120) in combination with azacitidine (AZA) for newly diagnosed acute myeloid leukemia (ND AML) Meeting Abstract
| Authors: | Dinardo, C. D.; Stein, A. S.; Stein, E. M.; Fathi, A. T.; Frankfurt, O.; Schuh, A. C.; Martinelli, G.; Patel, P. A.; Raffoux, E.; Tan, P.; Zeidan, A. M.; de Botton, S.; Kantarjian, H. M.; Stone, R. M.; Lam, D. H.; Gong, J.; Zhang, V.; Winkler, T.; Wu, B.; Vyas, P. |
| Abstract Title: | Mutant IDH1 inhibitor ivosidenib (IVO; AG-120) in combination with azacitidine (AZA) for newly diagnosed acute myeloid leukemia (ND AML) |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 408s |
| Language: | English |
| ACCESSION: | WOS:000487345806214 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2019.37.15_suppl.7011 |
| Notes: | Meeting Abstract: 7011 -- Source: Wos |
